MicroPort Scientific (0853) is a CN-listed Healthcare company in Medical - Devices with a market capitalization of HK
3.3B, trading at HK$6.93 on the HKSE. This SniperIQ fundamentals page covers MicroPort Scientific's valuation (P/E 35.6x, P/B 1.5x), profitability (net margin 4.9%), revenue ($996M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Market CapHK
3.3B
P/E (TTM)35.6x
Net Margin4.9%
Revenue (FY25)$996M
Full research coverage
8-Quarter Revenue & Margin Trend
Debt Maturity & Coverage
Peer Valuation Comparison
Free Cash Flow & Owner Earnings
AI Signal + Institutional Flow
DCF Valuation Model
Frequently Asked Questions
What is MicroPort Scientific's market cap?
MicroPort Scientific (0853) has a market capitalization of approximately HK
3.3B, trading at HK$6.93 on the HKSE. Market cap moves with the live share price.
What is MicroPort Scientific's P/E ratio?
MicroPort Scientific's trailing twelve-month P/E ratio is 35.6x, with a price-to-book (P/B) of 1.5x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is MicroPort Scientific?
MicroPort Scientific runs a net profit margin of 4.9%, a gross margin of 55.2%, and an operating margin of -3.7%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does MicroPort Scientific generate?
MicroPort Scientific reported revenue of $996M for fiscal year 2025, with net income of $49M and earnings per share (EPS) of 0.0257. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does MicroPort Scientific pay a dividend?
MicroPort Scientific does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is MicroPort Scientific financially healthy?
MicroPort Scientific carries a debt-to-equity ratio of 1.63x and a current ratio of 1.45x, with a market beta of 0.34. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is MicroPort Scientific a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For MicroPort Scientific (0853) the key facts are: market cap HK
3.3B, P/E 35.6x, revenue $996M, 52-week range 5.83-16.28. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track MicroPort Scientific's full fundamentals live
Get MicroPort Scientific's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.